Encompass Health Corporation
HealthcareNYSE:EHC · New York Stock Exchange
-$0.41 today
Vol 0.45M · Avg 0.92M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$6.1B of revenue converted into $609.2M of net income for the selected period. Gross margin is 58.5% and net margin is 10.0%, showing how much revenue survives after costs and taxes. EPS is $5.99, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B +10.5% | $5.4B +11.9% | $4.8B +10.4% | $4.3B +8.3% | $4.0B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $254.4M -91.9% | $3.1B +11.4% | $2.8B +8.6% | $2.6B +12.3% | $2.3B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $5.7B +154.4% | $2.2B +12.6% | $2.0B +13.1% | $1.8B +2.9% | $1.7B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 95.7% +54.2pp | 41.6% +0.3pp | 41.3% +1.0pp | 40.3% -2.1pp | 42.4% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $3.4B +1180.0% | $266.5M +3.3% | $258.0M +23.4% | $209.0M -8.5% | $228.5M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $4.6B +238.1% | $1.4B +430.5% | $258.0M -77.0% | $1.1B +7.6% | $1.0B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $327.9M +9.4% | $299.6M +9.4% | $273.9M +12.4% | $243.6M +10.9% | $219.6M | $374.2M | $1.2B | $631.8M |
| EBITDA | $1.4B +18.3% | $1.2B +18.0% | $1.0B +15.6% | $870.1M -2.1% | $888.9M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 23.7% +1.6pp | 22.1% +1.1pp | 20.9% +0.9pp | 20.0% -2.1pp | 22.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | $1.1B +21.8% | $864.5M -49.9% | $1.7B +173.7% | $630.2M -4.4% | $659.4M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 17.7% +1.7pp | 16.1% -19.8pp | 35.9% +21.4pp | 14.5% -1.9pp | 16.4% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $123.2M -10.3% | $137.4M -4.3% | $143.5M -18.3% | $175.7M +6.9% | $164.3M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$100.1M +12.9% | -$114.9M +89.7% | -$1.1B -523.0% | -$179.4M -16.2% | -$154.4M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $953.0M +27.1% | $749.6M +23.5% | $607.2M +34.7% | $450.8M -10.7% | $505.0M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 16.1% +2.1pp | 14.0% +1.3pp | 12.6% +2.3pp | 10.4% -2.2pp | 12.6% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $192.9M +28.4% | $150.2M +13.6% | $132.2M +32.1% | $100.1M -1.8% | $101.9M | $1.3B | -$1.6B | $745.2M |
| Net Income | $566.2M +24.2% | $455.7M +29.5% | $352.0M +29.9% | $271.0M -34.3% | $412.2M | $4.9B | $4.8B | $4.7B |
| Net Margin | 9.5% +1.1pp | 8.5% +1.1pp | 7.3% +1.1pp | 6.2% -4.0pp | 10.3% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $6 +24.1% | $5 +28.0% | $4 +30.1% | $3 -34.5% | $4 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $6 +24.2% | $4 +28.5% | $3 +28.5% | $3 -34.3% | $4 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $100.5M +0.6% | $99.9M +0.4% | $99.5M +0.3% | $99.2M +0.2% | $99.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $102.2M +0.0% | $102.2M +0.9% | $101.3M +0.9% | $100.4M +0.2% | $100.2M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Solventum Corporation
NYSE:SOLV
$13.54B
DaVita Inc.
NYSE:DVA
$13.46B
Align Technology, Inc.
NASDAQ:ALGN
$12.50B
Fresenius Medical Care AG & Co. KGaA
NYSE:FMS
$12.37B
Elanco Animal Health Incorporated
NYSE:ELAN
$12.06B
ICON Public Limited Company
NASDAQ:ICLR
$11.19B
Dr. Reddy's Laboratories Limited
NYSE:RDY
$11.11B
Universal Health Services, Inc.
NYSE:UHS
$9.19B
The Ensign Group, Inc.
NASDAQ:ENSG
$8.68B
Chemed Corporation
NYSE:CHE
$5.58B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does EHC generate?
Encompass Health Corporation (EHC) reported $5.94B of revenue in fiscal 2025.
Is EHC profitable?
Encompass Health Corporation (EHC) reported $566.20M of net income, with a net margin of 9.5%.
Explore More
Continue the stock analysis
Jump to another research area for this company.